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Abstract
Autophagy is described to be involved in homeostasis, development and disease, both as a survival and a death process. Its
involvement in cell death proceeds from interrelationships with the apoptotic pathway. We focused on survival autophagy
and investigated its interplays with the apoptotic machinery. We found that while Mcl-1 remained ineffective, Bcl-2 and Bcl-
xL were required for starved cells to display a fully functional autophagic pathway as shown by proteolysis activity and
detection of autophagic vesicles. Such pro-autophagic functions of Bcl-2 and Bcl-xL were independent of Bax. However they
appeared to operate through non redundant mechanisms as Bcl-xL wielded a tighter control than Bcl-2 over the regulation
of autophagy: unlike Bcl-2, Bcl-xL and Atg7 manipulation yielded identical phenotypes suggesting they could be
components of the same signalling pathway; Bcl-xL subcellular localisation was modified upon starvation, and importantly
Bcl-xL acted independently of Beclin 1. Still an intact BH3-binding site was required for Bcl-xL to stimulate a fully functional
autophagic pathway. This study highlights that, in addition to their well-established anti-death function during apoptosis,
Bcl-2 and Bcl-xL have a broader role in cell survival. Should Bcl-2 and Bcl-xL stand at the cross-roads between pro-survival
and pro-death autophagy, this study introduces the new concept that the regulation of autophagy by Bcl-2 and Bcl-xL is
adjusted according to its survival or death outcome.
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Introduction
Macro-autophagy (hereafter referred to as autophagy) is a
catabolic process orchestrated by the evolutionary conserved ATG
genes (for autophagy) [1,2], and consist in the random sequestra-
tion of macromolecules by newly formed double or multiple
membrane bound vesicles called autophagosomes. Owing to their
size (usually between 500–1500 nm in mammalian cells) [3,4],
autophagosomes can enclose soluble material as well as whole
organelles. Degradation of the cargo is achieved after nascent
autophagic vacuoles have fused with lysosomes [5]. The resulting
products are then available for recycling in biosynthetic pathways;
thus autophagy is one of the main lysosomal pathways for
biological material turnover.
Autophagy was initially characterised as a survival mechanism
since it allows cells to overcome stringent conditions thereby
extending the life span. Upon starvation, mutations in ATG genes
result in cell death in yeast, chlorosis in plants, and decreased adult
life span in the daf-2 Caenorhabditis elegans mutant [1]. In
mammals, autophagy exists at a basal level and controls
homeostatic functions. Stimulation of autophagy was long known
as a response to starvation or hormonal stimulation [6]; however,
recent studies have extended the cytoprotective role of autophagy
to maintenance of cell viability by showing that ATG genes are
necessary for survival in different settings in mammals [7–10].
Incidentally in these works, autophagy was elegantly shown to be
critical for bioenergetics maintenance and cell viability in vitro, but
also to play an essential part in vivo in the survival of the whole
organism.
Beside this physiological role in tissue homeostasis, autophagy is
also paradoxically associated with cell death. This concept arose
from the observation that autophagy is commonly seen in dying
cells when massive elimination is required in organs [11]. The
existence of ‘‘autophagic cell death’’ rather than ‘‘cell death with
autophagy’’ [12] was long questioned because autophagy and
apoptosis are often activated together in response to stress [13–15]
although displaying distinct morphologies [16]. Direct evidence of
an ATG-dependent cell death was brought both by loss of function
studies showing that the down-regulation of ATG7 or ATG5 could
suppress cell death in apoptosis-deficient cells [17,18], and also by
over-expression experiments showing that ectopic expression of
mutants of ATG6/Beclin 1 could trigger autophagy stimulation
which resulted in ATG5-dependent cell death [19]. Thus,
autophagy can be envisaged as an alternative death program, at
least in cells with impaired apoptosis machinery. Yet, if autophagic
death is now acknowledged, the causal event for its onset is still
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initiator of death has been reported, and (ii) evidence is still lacking
of a stimulus that would skew pro-survival autophagy into a deadly
program.
More recently, the field of interest for autophagic cell death has
widened due to the finding that autophagy deregulation is
implicated in cancer, and because molecular interplays have
substantiated a crosstalk between apoptosis and autophagy [20].
Hence, the fate of cells is undoubtedly ruled by the coordinated
regulation of apoptosis and autophagy, but the when and how are
still unresolved questions [21,22]. One decisive breakthrough as to
this latter point was the finding that the key regulator of autophagy
Beclin 1 harbours a BH3 domain [23] which binds to the BH1-
BH2 domains of anti-apoptotic Bcl-2 [19] or Bcl-xL [24].
Consecutively, thorough analyses of the regulation of autophagy
by Bcl-2 and Bcl-xL were undertaken and revealed that their
binding to Beclin 1 resulted in the inhibition of autophagy. This
binding was initially proposed to divert Beclin 1 from interacting
with and stimulating class III phosphatidylinositol-3-kinase Vps34
activity [19], but a consensus now argues against a mutually
exclusive interactions of Beclin 1 with Bcl-2 and Vps34 [24–26],
underlining that autophagic activity is not solely driven by Beclin 1
association with Bcl-2/Bcl-xL. Accordingly, Zeng et al. have
reported settings where Beclin 1 does not bind Bcl-xL nor Bcl-2
[27], showing that these interactions are not obligate. All these
observations indicate that the functional relevance of Bcl-2/Beclin
1 or Bcl-xL/Beclin 1 interactions is not fully understood yet. Even
more, the view of Bcl-2 as an anti-autophagic protein [28–30] was
challenged by the finding that over-expression of Bcl-2 in
apoptosis-deficient cells could instead potentiate autophagy [18].
To further investigate this topic, we decided to explore the
autophagic functions of Bcl-2 family members under conditions
where autophagy stimulation serves as a survival process: similar to
what was observed with death-promoting autophagy, we found
that survival autophagy is specifically entangled with anti-
apoptotic functions of Bcl-2 and Bcl-xL; however interestingly,
they were both found to stimulate autophagy and exhibited
different dependence on Beclin 1 to play such pro-survival
functions.
Results
Starvation-Induced Autophagy Is a Survival Process in
HCT116 Cells
The controversy as to the pro-survival [7,10] or pro-death
[17–19] outcome of the manipulation of autophagy under nutrient
limiting conditions has been fueled by the confrontation of several
studies. Therefore we first set out to address the fate of starved cells
in our settings: colorectal HCT116 cells were chosen as they
appeared, among the all the cell lines we have tested, to exhibit the
strongest autophagic response when confronted to nutrient
limitation (our unpublished data). Cells were transferred into
starvation medium and followed by video microscopy over
48 hours. Morphometric analyses (Fig. 1A) revealed that
HCT116 parental cells mostly displayed apoptotic features
(,55%) as confirmed by caspase 3 activation (Fig. 1B) while
,30% underwent a default death resulting from a rapid osmotic
demise (within 20 to 30 minutes after detachment from the plate),
and less than 5% remained alive. HCT116-BaxKO subclone was
also analysed to assay the outcome of starvation in apoptosis
deficient cells: as expected morphometric analysis (Fig. 1A) and
western blot (Fig. 1B) failed to detect any apoptotic feature, and we
observed that the fraction of cells undergoing the osmotic demise
remained unchanged (,30%). Interestingly, another phenotype
predominated as more than 50% of HCT116-BaxKO cells
detached from the plate but maintained viability since they
recovered normal adherence and proliferation when transferred
back into complete medium (Fig. 1C). Of note, these detached
cells could not account for mitotic cells after 48 hours of starvation
since nutrient limitation is known to induce a rapid cell cycle arrest
Figure 1. Starvation stimulates survival autophagy in HCT116
cells. (A) Morphometric analyses of cells starved for 48 hours. Cells
were plated in complete media and time-lapse video microscopy was
started upon transfer into HBSS. Viable cells are defined as adherent
cells, apoptotic cells are defined as cells exhibiting multiple membrane
blebs, death by loss of osmotic integrity is defined as cells displaying
the swelling of a single bleb, and stasis cells are defined as cells that
have detached from the substratum but maintain plasma membrane
integrity. A minimum of 700 cells were analysed over triplicate
experiments. Scale bar: 50 mm. (B) Western blots showing caspase 3
activation and Atg5-Atg12 conjugate in whole cells extracts from cells
starved for the indicated times. (C) The non-adherent HCT116-BaxKO
cells from 24 hours-starved cultures were collected and transferred into
complete medium. Cells were allowed to adhere for 6 hours, then time-
lapse video microscopy was started for 48 hours. Scale bar: 100 mm.
doi:10.1371/journal.pone.0008755.g001
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of the autophagic metabolically quiescent phenotype Lum et al.
have described [10], we next assayed the requirement for a
functional autophagic machinery. Autophagy uses two ubiquitin-
like conjugation systems for autophagosomes completion, which
both involve Atg7, a protein reminiscent of the E1 ubiquitin-
activating enzymes [32] essential for autophagy [33]. As a result,
Atg5 is conjugated to Atg12 when autophagy is activated; western
blot revealed that starvation massively induced autophagy in
HCT116 BaxKO subclone compared to parental cells (Fig. 1B).
Genetic impairment of autophagy was also performed using
shRNA targeting of Atg7, and starved HCT116-BaxKO shAtg7
cells were found to undergo massive osmotic cell death (,80%)
due to defective entry into the autophagic stasis state (,5%)
(Fig. 1A), as confirmed by the dramatic decrease in Atg5-Atg12
conjugate in these cells (Fig. 1B). The stasis state was thus
dependent on autophagy and proved a means to keep death at
bay. We conclude that, although transient because cells eventually
die if starvation is prolonged, autophagy confers a survival
advantage in our settings.
The Autophagic Capacities of Colorectal HCT116 Cells Is
Independent of Bax
The previous experiment suggested that when cells can execute
both apoptosis and autophagy, apoptotic phenotypes prevail over
autophagic features. We were therefore concerned by the
possibility that the autophagic response could indeed be impaired
by the execution of apoptosis. To address this question, we have
compared the autophagic capacity of HCT116 and HCT116-
BaxKO cells under conditions where macroautophagy is the
predominant form of protein degradation, namely after 6–9 hours
of starvation [34]. Fig. 2A shows the degradation of L-[
14C]valine-
labeled long-lived proteins. The basal proteolysis measured under
control conditions was comparable in both cell lines and
respectively set as the internal reference (white bars). Starvation
similarly resulted in a two-fold increased proteolysis in both cell
lines (black bars). This proteolysis was (i) essentially lysosomal since
Bafilomycin A1 (Baf A1, an inhibitor of lysosomal ATPase proton
pump) completely prevented its augmentation (dark gray bars),
and (ii) associated with autophagy since its stimulation was
significantly reversed by 3-MA (light gray bars). As a control, an
apoptotic induction by etoposide over the same period of time did
not stimulate any proteolysis (hatched bars). We also assayed the
conversion of cytosolic Atg8/LC3-I into the autophagosome-
bound phosphatidylethanolamine conjugate LC3-II, which is one
of the hallmarks of autophagy. Western blots (Fig. 2B) confirmed
that HCT116 and HCT116-BaxKO both produced comparable
amounts of LC3-II upon starvation. The diffuse cytosolic of
punctate localisation of mCherry-LC3 was also monitored in
mouse embryonic fibroblasts (MEFs) as an alternative cell line, and
showed that starvation triggered the same autophagosomal
relocalisation of LC3 in wild-type MEFs and Bax knocked-out
MEFs (Fig. S1). Taken together, our experiments show that
apoptosis execution does not impair the autophagic response, and
we conclude that the autophagic capacity is independent of Bax.
Ectopic Expression of Bcl-2 and Bcl-xL, but Not Mcl-1,
Stimulates Autophagy
The latter result provided grounding for our resolution to use
the apoptosis-deficient subclone HCT116-BaxKO to address the
regulation of pro-survival autophagy by anti-apoptotic proteins,
while separating the contribution of the Bcl-2 family members to
apoptosis. HCT116-BaxKO cells were transfected with plasmids
encoding either Bcl-2, Bcl-xL or Mcl-1, resulting respectively in 9,
2 and 3 fold protein increase (Fig. 3A). Starvation did not modify
the expression profiles (Fig. S2). Video microscopy of starved cells
showed that over-expression of Bcl-2 and Bcl-xL significantly
increased the number of cells entering the autophagic stasis state
(Fig. 3B, respectively 88% and 82%), whereas Mcl-1 over-
expression augmented instead the number of viable adherent cells
(Fig. 3B, white bar =48%). Thus, Bcl-2 and Bcl-xL clearly had a
different effect than Mcl-1 on autophagy. This was confirmed by
autophagic proteolysis (Fig. 3C) and transmission electron
micrographs (TEM) wherein degradative vesicles were more
abundant in cells expressing Bcl-2 and Bcl-xL while those
expressing Mcl-1 remained as untransfected cells (Fig. 3D, and
Fig. S3 for magnification); of note, occasionally, extensive
vacuolisation appeared in the cytoplasm of cells over-expressing
Bcl-xL (Fig. 3D, left panel). When we used BaxKO MEFs and
monitored mCherry-LC3 fluorescence pattern, we found that the
relocalisation of the protein toward punctate structures was
significantly stimulated in Bcl-2 or Bcl-xL transfected cells
(Fig. 3E), thus showing that the phenomenon was conserved in
an alternative cell line. All the gold standard techniques used so far
unanimously showed that only autophagic vesicles (AVs) are
affected by Bcl-2 or Bcl-xL over-expression while other lipidic
vesicles like multi-vesicular bodies are not; therefore we used
Figure 2. HCT116 and HCT116-BaxKO cells display comparable
autophagic capacities. (A) HCT116 and HCT116-BaxKO cells were
incubated with L-[
14C]valine, and chased for 9 hours in complete
medium (white bars), HBSS (black bars) or HBSS supplemented with
either 0,1 mM Baf A1 (dark gray bars), or 10 mM 3-MA (light gray bars),
or in complete medium +20 mM etoposide (hatched bars). Results
report the stimulation of proteolysis relative to the respective basal
levels measured under non-starving conditions (white bars). The values
are the means of at least 3 independent experiments 6 s.d. (B) Western
blot and quantification of the conversion of LC3-I into phosphatidyl-
ethanolamine-conjugated LC3-II. Cells were grown in complete medium
or starved for 9 h in the presence of E-64d (20 mg/ml) and leupeptine
(20 mg/ml) to prevent the degradation of intra-autophagosomal LC3-II.
150 mg whole cell lysate were loaded on 15% SDS-PAGE. *Student test
p,0,02.
doi:10.1371/journal.pone.0008755.g002
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PLoS ONE | www.plosone.org 3 January 2010 | Volume 5 | Issue 1 | e8755Figure 3. Bcl-2 and Bcl-xL stimulate survival autophagy while Mcl-1 does not. (A) Western blots of cells transfected with an empty vector,
or vectors encoding Bcl-2 or Bcl-xL or Mcl-1. 50 mg of protein extracts were analysed on a 12% SDS-PAGE. Mcl-1 was detected as a mature protein (m),
a spliced variant (s) and a caspase-cleaved product (c). (B) Morphometric analyses of HCT116-BaxKO-derived stable cell lines: cells were plated in
complete media and time-lapse video microscopy started when cells were transferred to HBSS (starvation) or not (complete). A minimum of 700 cells
were analysed in at least triplicate experiments. (C) Relative stimulation of starvation-induced 3-MA-sensitive degradation of long-lived proteins in
HCT116-BaxKO cell lines transfected or not with Bcl-2 or Bcl-xL or Mcl-1. Cells were chased for 6 hours in HBSS or HBSS + 3-MA. The 3-MA sensitive
activity measured in HCT116-BaxKO cells was set at 1 and results represent the 3-MA sensitive activities of each cell line relative to that found in
untransfected cells. Data are the mean (6s.d.) of at least 3 independent experiments. Student test was used for statistics significance of the results
compared to untransfected cells: (*)p=0,010 (**)p=0,001 and (***)p=0,479. (D) TEM of HCT116-BaxKO cells over-expressing Bcl-2 or Bcl-xL or Mcl-1
after 6 hours of starvation in HBSS. Arrows point at degradative autophagosomes. Scale bar: 2 mm. (E) 24 h after transfection either with mCherryLC3
alone, or with mCherryLC3 and Flag-Bcl-xL or Flag-Bcl-2, BaxKO MEF cells grown in complete medium or starved for 6 hours were fixed.
Immonocytochemistry reveals Flag-tagged constructs (green). Pictures are representative of at least 4 independent experiments. Scale bar: 10 mm.
doi:10.1371/journal.pone.0008755.g003
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proved to stain AVs [36]) to run computer-assisted analyses of
AVs, measure their size, and determine their frequency of
detection (Fig. S4): starved HCT116-BaxKO cells transfected
with Bcl-2 or Bcl-xL revealed an augmentation of the number of
AVs, correlated with an increased frequency of appearance of
larger AVs, some being twice as big as classical autophagosomes as
confirmed by occasional TEM. On the opposite, Mcl-1 transfected
cells were not statistically different from untransfected cells. Hence
we conclude that, while Mcl-1 does not play an essential role in
survival autophagy, Bcl-2 and Bcl-xL specifically stimulate the
autophagic capacity and increase the AVs number and size.
Down-Regulation of Bcl-xL Is a More Potent Inhibitor of
Autophagy Than That of Bcl-2
We next explored the effect of Bcl-2 and Bcl-xL down-
regulation as compared to that of Atg7 in starved cells. A
multiplicity of infection (MOI) of 4 caused at least a 90% silencing
of the target genes (Fig. 4A) without any cross effect on each other
(not shown). Over the time frame of the experiment, viability of
transduced cell remained at control values (.90%, data not
shown) both in complete medium or after the 6h starvation. TEM
showed that double membrane bound vesicles were barely
detectable in starved cells wherein Bcl-2, Bcl-xL or Atg7 had
been down-regulated as compared to SCR transduced cells
(Fig. 4B). The plasmid used to transduce the shRNAs encodes
the green fluorescent protein (GFP) and we could thus correlate
the efficiency of infection with the autophagic response revealed by
mCherryLC3 localisation (Fig. 4C). Upon starvation, cells
displaying a high degree of transduction with shAtg7 (highly
GFP-positive cells) exhibited a diffuse cytosolic distribution of
mCherryLC3 showing that autophagy was efficiently impaired,
while non transduced cells displayed punctate mCherryLC3
organisation. In keeping, starved cells wherein shBcl-2 or shBcl-
xL had been efficiently transduced exhibited a diffuse mCher-
ryLC3 staining, although shBcl-xL reproducibly triggered a
stronger inhibitory phenotype than shBcl-2. Thus, Bcl-2 or Bcl-
xL down-regulation had an inhibitory effect on autophagy,
however this experiment could indicate that Bcl-2 and Bcl-xL
may not be completely redundant for the molecular control of
survival autophagy. In an attempt to quantify such a difference, we
finally assayed starvation-induced proteolysis of shRNAs trans-
duced cells: for a MOI of 4, Bcl-2 knocked-down cells retained
75% of the 3-MA sensitive proteolysis as compared to a scramble
shRNA (SCR). This plateau was already reached with a MOI of 2
and remained unchanged even for higher MOIs (not shown). In
contrast, Bcl-xL and Atg7 silencing decreased the degradation rate
respectively to 15 and 17% (Fig. 4D). Hence, Bcl-2 and Bcl-xL
knock-down both had a compelling inhibitory effect on autophagic
proteolysis. However, only Bcl-xL down-regulation mimicked that
of Atg7 and proved a key molecular control of autophagy.
Bcl-xL Regulates Survival Autophagy Independently of
Beclin 1
Studies reporting anti-autophagic functions of Bcl-2 and Bcl-xL
depict conditions where stimulated autophagy resulted in cell death,
and showed that their binding to Beclin 1 blocked the onset of
autophagy. On the opposite, Zeng et al. reported that in non-starved
U-251 glioblastoma cells, neither Bcl-2 nor Bcl-xL were normal
endogenous binding entities for Beclin 1 [27], suggesting that
depending on the settings, these proteins are not obligate partners.
In our paradigm of cytoprotective autophagy, endogenous
Beclin 1 was immunoprecipitated from control or starved cell
lysates (Fig. 5A). Bcl-2 was efficiently pulled down but not Bcl-xL;
of note, Bcl-2/Beclin 1 association did not vary in starved versus
control cells. The converse immunoprecipitation of endogenous
Bcl-2 confirmed these observations, while Bcl-xL again failed to
pull-down any detectable Beclin 1. These experiments support a
differential regulation of pro-survival autophagy by Bcl-2 and Bcl-
xL, but further experiments were needed to ascertain that Bcl-xL
acted independently of Beclin 1. Subcellular fractionation showed
that excepting the mitochondrial portion of Bcl-2, substantial
amounts of Bcl-2 and Beclin 1 overlap in light fractions, and in
further keeping with IP results, none of these proteins changed
localisation in control or starved cells. In contrast, Bcl-xL was
detected throughout the whole gradient in control cells and was
relocalised to very light fractions in starved cells; given the number
of compartments in which Bcl-xL is present, it is reasonable to
assume that it may interact with many partners, and this may
account for the fact that Beclin 1 is not found as its main
interacting partner through IP experiments. Confocal analyses
showed that Bcl-xL co-localised with the mitochondrial inner
membrane protein Atp1 in control and starved cells (Fig. 5C);
hence the light fractions hosting Bcl-xL in starved cells are in the
close vicinity of mitochondria.
Because IP experiments showed an interaction between Bcl-2
and Beclin 1 but were inconclusive for Bcl-xL and Beclin 1, we
finally decided to set up a last array of experiments to further
explore the functional differences between Bcl-2 and Bcl-xL and
their dependence on Beclin 1. We analysed autophagy in cells
over-expressing Beclin 1 or the BH3 mutants Beclin 1
F123A and
Beclin 1
125A which respectively loose or retain their binding to Bcl-
2 and Bcl-xL[19,37] (protein expression levels are shown in Fig.
S5). Fig.6A shows that, as expected, Beclin 1 ectopic expression
stimulated starvation-induced autophagic proteolysis. Such a trait
was strictly dependent on a functional BH3 domain (i.e. able to
interact with BH1-BH2 containing partners) since Beclin 1
125A
mimicked the wild type protein, while Beclin 1
F123A was
completely unable to trigger autophagy. The BH1 mutants of
Bcl-2 and Bcl-xL (i.e. Bcl-2
G145A or Bcl-xL
G138A), which both loose
their interaction with the BH3 domain of Beclin 1 [19,24] were
reciprocally analysed. Levels of over-expression in HCT116-
BaxKO cells were similar to those of ectopic Bcl-2 and Bcl-xL (Fig.
S2). Preventing the binding of Bcl-2 to Beclin 1 completely
abrogated the stimulation of autophagic proteolysis observed with
native Bcl-2. TEM confirmed that the amount and size of
autophagic vesicles in Bcl-2
G145A expressing cells were very
different from Bcl-2 expressing cells, and were indeed comparable
to non transfected cells (compare Fig. 3D and Fig. 6B right).
Therefore, Bcl-2 pro-autophagic functions entirely rely on the
binding of a BH3 containing partner (probably Beclin 1 according
to IP experiments and to proteolysis data obtained with Beclin
1
F123A). In contrast, Bcl-xL
G138A still retained a slight capacity to
stimulate autophagic degradation, although it was far less efficient
than its native counterpart (Fig. 6A). TEM indicated that Bcl-
xL
G138A stimulated AVs synthesis as efficiently as Bcl-xL (compare
Fig. 6B left with Fig. 3D). Relocalisation of mCherry-LC3 in
BaxKO-MEFs transfected with Bcl-xL
G138A confirmed this
observation (compare Fig. 6C with Fig. 3E). Colocalisation of
LC3 and Lamp1A in starved HCT116 BaxKO cells expressing
Bcl-xL or Bcl-xL
G138A showed that autophagic vesicles contained
both markers, and hence represent degradative autophagosomes.
Therefore, the mutation of Bcl-xL BH3 binding site resulted in a
structurally intact but functionally impaired autophagic pathway.
This set of data indicate that degradative AVs are formed in Bcl-
xL
G138A but further experiments are needed to explain why these
AVs are less functional than in Bcl-xL expressing cells.
BclxL Cytoprotective Functions
PLoS ONE | www.plosone.org 5 January 2010 | Volume 5 | Issue 1 | e8755Figure 4. Silencing of Bcl-2 and Bcl-xL has non-redundant effects on autophagy. (A) Western blots of HCT116-BaxKO cells infected with
increasingamounts ofviral particles transducingshRNA againstBcl-2,Bcl-xL or Atg7,or a scrambledshRNA (SCR). Total protein extracts were performed,
and 50 mg proteins were analysed on SDS-PAGE. (B) HCT116-BaxKO cells infected with viral particles carrying shRNA against Bcl-2, Bcl-xL or Atg7 with a
MOI=4wereanalysedforautophagicdegradationoflong-livedproteinsshortly afterinfection.Cellswerechasedfor6 hoursinHBSSorHBSS+10 mM3-
MA. 3-MA sensitive activity measured in SCR-infected cells was set to 100%, and results represent the 3-MA sensitive activities of each infected cell line
relative to that found in SCR-infected cells. Data arethe mean (6s.d.) of at least 3 independent experiments. When theerror is not indicated, barwas too
small to be seen. (C) HCT116-BaxKO cells stably transfected with mCherryLC3 were infected with viral particles carrying shRNA against Bcl-2, Bcl-xL or
Atg7 with a MOI=4.Cellswere analysed for their GFPfluorescence (infectedcells) andLC3relocalisationafter6 hoursof starvation.Scalebar: 15 mm. (D)
TEM after 6 hours of starvation of HCT116-BaxKO cells where Bcl-2 or Bcl-xL or Atg7 expression was silenced. Scale bar: 2 mm.
doi:10.1371/journal.pone.0008755.g004
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transfected cells or in cells expressing Bcl-xL or Bcl-xL
G138A failed
to identify any difference, indicating that the conjugation step is
not limiting and cannot be further stimulated by Bcl-xL expression
(Fig. S6). Future experiments will aim at comparing the kinetics of
AVs maturation in Bcl-xL and Bcl-xL
G138A expressing cells. As a
conclusion, Bcl-2 and Bcl-xL exhibit a differential dependence on
Beclin 1 do display their pro-autophagic functions. While Bcl-2
fully relies on its binding to Beclin 1, Bcl-xL does not control the
formation of autophagosomes via Beclin 1, and we propose that a
protein which uses the BH3-binding domain helps Bcl-xL
stimulating a functional autophagic pathway.
Discussion
The molecular bases to predict the cytoprotective or the pro-
death outcome of autophagy are still a topic of intense
investigation as the execution of the former or the latter drives
cells toward opposite fate. Addressing the interplays between
apoptosis and autophagy was one way to approach this issue.
Settings in which the stimulation of autophagy results in
autophagic cell death [19] have pointed at direct interactions
between Beclin-1 and Bcl-2 or Bcl-xL as potential convergence
point for the two death processes that are apoptosis and
autophagy. We resolved to study the converse regulation of pro-
survival autophagy by Bcl-2 family members. A wide discrepancy
has been reported in the autophagic response of cancer cells [20],
and colorectal HCT116 cells were chosen for this study as highly
responsive cells when confronted to starvation (our unpublished
data). Our settings delineated a ‘‘stasis state’’ strictly correlated to
autophagy, and which proved to be a reversible quiescent
phenotype allowing cells to sustain viability during nutrient
restriction (Fig. 1). Such cytoprotective autophagy appeared
independent of Bax (Figs 2, S1), which allowed us to choose the
Figure 5. Differences between Bcl-2 and Bcl-xL behaviour during autophagy. (A) Co-immunoprecipitation of endogenous Beclin 1 with
endogenous Bcl-2 and Bcl-xL in HCT116-Bax KO cells grown in complete medium or starved for 6 hours. (B) Subcellular fractionation of HCT116-Bax
KO cells grown in complete medium or starved for 6 hours. Cells were broken with a Dounce homogeniser, post-nuclear supernatants were loaded
on top of a continuous 10–55% sucrose gradient for ultracentrifugation overnight. Fractions of 500 ml were collected, and total protein precipitated.
The same volume of each fraction was separated on a 14% tris-tricine SDS-PAGE. Western-blots were as described in the methods section. (C)
Immunocytochemistry on endogenous Bcl-xL and ATP1 in HCT116-BaxKO cells grown in complete medium or starved for 6 hours.
doi:10.1371/journal.pone.0008755.g005
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PLoS ONE | www.plosone.org 7 January 2010 | Volume 5 | Issue 1 | e8755Figure 6. Requirement for an intact BH3 binding site for Bcl-2 and Bcl-xL pro-autophagic functions. (A) Relative stimulation of starvation-
induced 3-MA-sensitive degradation of long-lived proteins in HCT116-BaxKO cell lines transfected or not with Bcl-2, Bcl-2
G145A, Bcl-xL, Bcl-xL
G138A, Beclin
1, Beclin 1
F123A or Beclin 1
I125A. Cells were chased for 6 hours in HBSS or HBSS + 3-MA. Results represent the 3-MA sensitive activities of each cell line
relative to that found in untransfected cells. Data are the mean (6s.d.) of at least 3 independent experiments. Student test was used for statistics
significance of the results compared to untransfected cells; p values not indicated on the graph are p,0,01. (B) TEM of HCT116-BaxKO cells transfected
with Bcl-xL
G138A (left) or Bcl-2
G145A (right) after 6 hours of starvation. Scale bar: 2 mm. (C) 24 h after cotransfection of mCherryLC3 with Flag-Bcl-xL
G138A,
BaxKO MEFs grown in complete medium or starved for 6 hours were fixed. Immonocytochemistry reveals Flag-tagged constructs (green). Pictures are
representative of at least 4 independent experiments. Scale bar: 10 mm. (D) HCT116BaxKO cells over-expressing Bcl-xL or Bcl-xL
G138A were transfected
with mCherryLC3 and mEGFP-Lamp1A. After 6 h of starvation, cells were fixed and observed with a 100x objective (scale bar: 5 mm).
doi:10.1371/journal.pone.0008755.g006
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autophagic functions of Bcl-2 family members while circumvent-
ing their commitment to apoptosis regulation. Cytoprotective
autophagy appeared to be specifically regulated by Bcl-2 and Bcl-
xL, not by Mcl-1. Opposite to autophagic cell death, survival
autophagy was stimulated by Bcl-2 and Bcl-xL, as unanimously
shown by proteolysis experiments, TEM and LC3 re-localisation
assays based on over-expression and silencing of the two proteins.
Bcl-2 and Bcl-xL also seemed committed in the regulation of AVs
synthesis, but apparently through non redundant mechanisms
(Fig. 4, 5, 6). Such observations are in keeping with Shimizu et al.,
who already suggested possible functional differences between Bcl-
2 and Bcl-xL for the stimulation of autophagy [18]. We found that,
indeed, Bcl-xL wielded a tighter control than Bcl-2 over AVs
production (Fig. 4), and gathered evidence that Bcl-xL and Atg7
could belong to the same pathway since the down-regulation of the
former phenocopied that of the latter (Fig. 4B, C). More
importantly, in this pathway Bcl-xL did not control autophagy
via Beclin 1 (Figs. 5 & 6).
Beclin 1 was reported to be engaged in different interactions
depending on the settings: the mammalian class III PI3-kinase
hVPS34 is documented as its major partner [27,38], this
interaction resulting in the stimulation of VPS34 by Beclin 1.
While the function of this tandem remains to be elucidated under
nutrient rich conditions [27], its is known to be essential in the
earliest steps of autophagosomes biogenesis during autophagy.
Pattingre et al. proposed that nutrient-driven regulation of Beclin
1/hVPS34 interaction was mediated by Bcl-2: when nutrients are
abundant, Bcl-2/Beclin 1 interaction would be stabilised at the
expense of Beclin 1/hVPS34 binding [19]. At odds with this
scheme, under nutrient rich conditions Zeng et al. never detected
any Bcl-2/Beclin 1 or Bcl-xL/Beclin 1 interactions [27], and other
studies showed that Beclin 1/hVPS34 and Bcl-2/Beclin 1 are non
mutually exclusive interactions [24–26]. In our settings, we found
that Bcl-2 interacted with Beclin 1: this interaction remained
unchanged by autophagy-promoting conditions (Fig. 5A) and was
absolutely required for Bcl-2 pro-autophagic functions (Fig. 6).
Maiuri et al showed that interactions between Beclin 1 and
mitochondrial Bcl-2 remained constant [24] while interactions
with ER-located Bcl-2 did not. In our settings, non mitochondrial
Bcl-2 can hardly account for an ER localisation (Fig. 5B); further
experiments are required to identify the host compartment and
characterise the molecular basis for such pro-autophagic functions.
Conversely, Bcl-xL did not interact with Beclin 1 in our model,
and accordingly BH3-binding defective mutant Bcl-xL
G138A
stimulated AVs formation as efficiently as native Bcl-xL (Fig. 3
& 6), suggesting Beclin 1-mediated AVs formation was not affected
by this mutation. However, we observed that Bcl-xL
G138A was less
efficient than Bcl-xL to stimulate autophagic proteolysis, and
therefore we cannot rule out the possibility that unknown
functions of Beclin 1 are yet to unveil, which would control steps
downstream of autophagosomal membrane nucleation, and would
depend on Bcl-xL binding. Our results suggest that both functions
would be separable since, opposite to the supposed alternative
function of Beclin 1, the formation of AVs is never impaired in our
model, providing a unique tool to address how Bcl-xL would
control it. An alternative explanation is that another protein, as yet
unidentified, is required for autophagosomes formation, and
activated by the binding of Bcl-xL, the interaction site encom-
passing the BH3 binding domain of Bcl-xL.
The array of functions a given protein can wield is strictly
dependent on its subcellular localisation. A major unsolved
question when considering the autophagic functions of Bcl-2 and
Bcl-xL was their respective localisation: Beclin 1 and hVPS34 are
reported to localise at the trans-golgi network, while enforced ER-
targeted Bcl-2 and Bcl-xL were reported to regulate autophagy
[19,24]. As observed by Pattingre et al., we confirmed that the
localisation of Beclin 1 did not vary depending on the cellular
nutrient status [19], but we found that in autophagic cells Bcl-xL
re-localised to lighter membrane fractions. So did Bcl-xL
G138A (not
shown). These observations may stand as another clue of a Beclin
1-independent regulation of autophagy by Bcl-xL, and widen the
array of partners available to account for Bcl-xL autophagic
functions. In light of our data, we subscribe to the proposition by
Luo and Rubinsztein who recently suggested that by virtue of their
interaction with BH3 containing proteins, Bcl-2/Bcl-xL may have
pro- or anti-autophagic functions [39]. Identification of Bcl-xL
binding partners under autophagic conditions is currently under
scrutiny in our laboratory.
To conclude, we found Bcl-2 and Bcl-xL stimulate survival
autophagy, and help the formation of autophagosomes through
non redundant mechanisms, Bcl-xL acting on the whole
independently of Beclin 1. When confronted to the literature,
our set of data supports the view that the regulation of autophagy
by Bcl-2 and Bcl-xL would be adjusted according to the survival or
death outcome of autophagy. Both pro- and anti-autophagic
functions have been attributed to Bcl-2 and Bcl-xL, the former
being related to cytoprotective autophagy, and the latter to
autophagy which leads to cell death. Remarkably, Bcl-2 and Bcl-
xL always retain pro-survival functions. Hence, these molecules
exceed the well-established anti-death functions they display
during apoptosis. Their role in the differential regulation of
autophagy, either as a cytoprotective mechanism or as a death
process, is still of particular interest with respect to cancer.
Materials and Methods
Materials
All cell culture material was obtained from Gibco (Invitrogen).
Unless stated otherwise, all chemicals were from Sigma. The
plasmids encoding mCherry-LC3 and monomeric EGFP-Lamp1A
were respectively kindly given by Pr T. Johansen [40] and Dr E.
Dell’Angelica [41]. Flag-tagged constructs were a kind gift of Dr P.
Juin.
Cell Lines and Cell Culture
HCT116 and HCT116-Bax KO were obtained from Dr B.
Vogelstein (Baltimore, USA). SV40 immortalised MEFs and Bax/
Bak double knocked-out MEFs were obtained from Dr. S
Korsmeyer.
HCT116 cells were grown in McCoy’s 5A. HEK293FT cells
and MEFs were grown in DMEM containing 4,5 g/L glucose. All
growth media were supplemented with 2 mM L-glutamine,
penicillin (100 U/mL), streptomycin (100 mg/mL) and 10% foetal
calf serum (FCS).
Stable cell lines were established from HCT116-BaxKO cells
transfected with pRc-CMV or pRc-CMV encoding Bcl-2, Bcl-xL,
Bcl-xL
G138A or Mcl-1. Cells (1610
6) were transfected with 10 mg
plasmid DNA using the Gene pulser II (Biorad) and two pulses of
250 V-850 mF. Stable cell lines were established by neomycin
(1 mg/mL) selection.
MEFs were transiently transfected using Fugene HD (Roche).
HIV-1 lentivirus-based vectors were used to introduce shRNAs
into HCT116-BaxKO cells. ShRNAs were cloned under the
control of U6 promoter between Bam-H1 and Hind-III sites in
pSilencer 2.1 (Ambion), according to the manufacturer’s proto-
cole. PCR amplified fragments were further subcloned between
Xba-I and Xho-I sites of FG12 lentivector [42]. HEK293FT cells
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previously described [42]. Human Bcl-2 siRNA, 59- CCG GGA
GAU AGU GAU GAA G –39, Bcl-xL siRNA, 59- AGG AUA
CAG CUG GAG UCA G -39 and Atg7 siRNA, 59- AGG ATA
CAG CTG GAG TCA G -39 were used.
Autophagy Assays
Autophagy was induced by amino acids and serum starvation:
cells were washed three times with PBS and incubated for 6 to
9 hours in Hank’s Buffered Salts Solution (HBSS) buffered with
2,2 g/L NaHCO3 and supplemented with 0,1% BSA.
The degradation of radio-active L-[
14C]valine-labeled long-
lived proteins was measured as follows: cells were incubated for
24 hours in complete medium with 0,1 mCi L-[
14C]valine to label
total proteins. Radio-activity was further pre-chased for 1 hour in
complete medium in the presence of an excess of L-valine
(10 mM) to remove the contribution of short-lived protein
degradation. Finally, cells were incubated for 6 to 9 hours either
in complete medium or in HBSS in the presence or in the absence
of 3-MA and with an excess of L-valine. Supernatants were
collected and free amino acids precipitated with 80% trichlor-
oacetic acid (TCA), while proteins in adherent cells were
precipitated with 10% TCA. Radio-activity was quantified in a
scintillation liquid analyser Tri-carb 2100TR (Packard). Proteol-
ysis is expressed as the percentage of free radio-activity released in
the supernatant relative to the total radio-activity.
TEM analyses of autophagy were done on fixed cells with 4%
glutaraldehyde in PBS (pH 7,4), followed by 2% OsO4 post-
fixation. After dehydration in a graded series of ethanol, adherent
cells were embedded in Epoxy resin, and thin sections (60 to
70 nm) were cut on a Reichert Ultracut E microtome and stained
with uranyl acetate and lead citrate for observation at 80 KV
under a JEM-1010 transmission electron microscope (JEOL).
Time-Lapse Analysis
Time-lapse video microscopy experiments were performed
using a Zeiss Axiovert 200-M inverted microscope and the
AxioVision 4.6 program. Dishes were placed inside an Incubator
XL-3, on a heating insert M06 (37uC) topped with a CO2-cover
HM connected to a CO2 controller that maintained environmen-
tal CO2 concentration at 5% for the duration of filming. Digital
pictures were acquired and saved every 10 minutes over 48 hours
using an AxioCam MRm digital camera. The series of
photographs were displayed as continuous time-lapse movies for
analyses.
Western Blot
Total proteins were extracted in 1% NP-40, 0,5% sodium-
deoxycholate, 0,1% SDS supplemented with protease inhibitor
MiniH from Roche Diagnostics. Protein concentration was
determined using BCA kit (Interchim). Protein extracts were
separated on SDS-PAGE or tris-tricine SDS-PAGE [43],
transferred onto PVDF membrane (Millipore) and revealed with
ECL (Roche Diagnostics). Primary antibodies were used at 1/1000
dilution: mouse monoclonal anti-actin (Chemicon), rabbit poly-
clonal anti-Atg5 (Sigma), rabbit polyclonal anti-Atg7 (Rockland),
mouse monoclonal anti-Bcl-2 (DakoCytomation), rabbit polyclon-
al anti-Bcl-x (Transduction Lab), rabbit polyclonal anti-calnexin
(Abcam), rabbit monoclonal anti-caspase 3 (Abcam), rabbit
polyclonal anti-LC3 (Cell Signaling), rabbit polyclonal anti-Mcl-
1 (Pharmingen), rabbit polyclonal anti-ERGIC-53 (Sigma), mouse
monoclonal anti-Flag (Sigma) and mouse monoclonal anti-porin
(Mitoscience LLC). Horseradish-peroxidase-conjugated secondary
antibodies were from Biorad. Quantifications were performed with
the software ImageJ.
Immunoprecipitation
Cells were resuspended in CHAPS buffer (1% CHAPS, 10 mM
HEPES, 150 mM NaCl, supplemented with protease inhibitors)
then disrupted by 3 cycles of freeze/thawing on ice. Cell debris
was removed by centrifugation (20 minutes at 13000 x g).
Immunoprecipitation was performed on 500 mg proteins, using a
Protein G-agarose Immunoprecipitation Kit (Sigma), and 2 mg
antibodies (mouse monoclonal anti-Beclin 1), rabbit monoclonal
anti-Bcl-2 (Epitomics), or rabbit monoclonal anti-Bcl-xL (Epi-
tomics). After elution, 1/5 of the eluted proteins were separated on
a 12% SDS-PAGE, and Western blot were as described above.
Immunocytochemistry
Cells were grown on gelatine-coated cover-slips. Cells were
fixed in 4% paraformaldehyde for 40 minutes, permeabilised with
0,1% SDS for 10 minutes, blocked with 3% BSA for 20 minutes,
and then incubated with primary antibodies for 1 hour followed
by secondary Alexa antibodies (Molecular Probes) for 30 minutes.
Cells were finally mounted either with Mowiol or Prolong antifade
(Molecular Probes, Invitrogen) polymerising solution, and ob-
served under a confocal microscope (LEICA TCS-SP1). Primary
antibodies were: mouse monoclonal anti-ATP1 (Molecular
probes), rabbit polyclonal anti-Bcl-X (Transduction Lab) and
anti-Flag antibody (Sigma).
Fluorescence Analysis
Images were acquired with an inverted microscope Olympus
IX81 CellR imaging system (100x objective). Stacks of 260 nm
step were acquired and images were deconvolved with iterative
deconvolution 3D plugins from Image J.
Supporting Information
Figure S1 Mouse embryonic fibroblasts wild type (SV40) or (b)
knocked-out for Bax (BaxKO) were transiently transfected using
Fugene HD (Roche) with mCherryLC3. Cells were grown on
gelatine-coated cover-slips, fixed in 4% paraformaldehyde for
40 mins, and washed. Cells were finally mounted with ProlongTM
antifade polymerizing solution (Molecular Probes, Invitrogen) and
observed on a Leica epifluorescence microscope.
Found at: doi:10.1371/journal.pone.0008755.s001 (0.45 MB TIF)
Figure S2 Stable HCT116 BaxKO cells expressing the
indicated proteins of the Bcl-2 family were either grown in
complete medium or starved for 6 or 24 h. Whole cell extracts
were performed and 100 mg of proteins were separated by SDS-
PAGE. Western blot was followed by immunodetection with actin
as loading control or the indicated antibodies.
Found at: doi:10.1371/journal.pone.0008755.s002 (0.36 MB TIF)
Figure S3 2x zoom of TEM presented in Fig. 3.
Found at: doi:10.1371/journal.pone.0008755.s003 (1.82 MB
PDF)
Figure S4 Stable HCT116 BaxKO cells expressing the
indicated Bcl-2 family proteins were grown on gelatin-coated
glass cover-slips to approximately 70% confluence either in
complete medium or starved for 6 h. Cover-slips were washed
with PBS, and incubated for 30 minutes with 200 mM MDH at
37uC in the dark then washed with PBS, and mounted for
immediate observation under UV (lex=359 nm) on a Leica
DMLB microscope. Digital pictures were acquired with a Leica
DC 300-F camera. Analyses of the images were done with a home-
BclxL Cytoprotective Functions
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assisted analyses were performed on 200 to 400 cells to determine
the diameter of all MDH-stained structures. The distribution of
the diameters was plotted by intervals of 0,2 mm, and the
frequency of occupation of these intervals labeled (% events). A
Student test was applied for statistic analysis: in transfected cells,
distributions under control conditions were not statistically
different from that of untransfected cells (p=0.42 for pBcl-2 cells,
p=0.24 for pBcl-xL cells, p=0.2 for Bcl-xLG138A cells, and
p=0.17 for pMcl-1 cells). Within each cell line, the distribution
under starved conditions was statistically different from their
respective control distribution (p,0.0001) except for Mcl-1
(p,0.4). Within each cell line, distributions under starved
conditions were statistically different from starved parental cells
(p,0,00005).
Found at: doi:10.1371/journal.pone.0008755.s004 (0.78 MB TIF)
Figure S5 HCT116 BaxKO cells were transfected with plasmids
encoding either Beclin 1 or the mutants Beclin 1 F123A or I125A.
Whole cell extracts were performed and 100 mg of proteins were
separated on SDS-PAGE. Western blot was followed by
immunodetection of Beclin 1. Quantification with Image J
software indicated that compared to endogenous level, the
overexpression levels were 1.7 in transfected cells.
Found at: doi:10.1371/journal.pone.0008755.s005 (0.11 MB TIF)
Figure S6 Stable HCT116 BaxKO cells expressing Bcl-xL or
Bcl-xL G138A were either grown in complete medium or starved
for 6 h. Whole cell extracts were performed and 75 mg of proteins
were separated on SDS-PAGE. Western blot was followed by
immunodetection of Atg5-Atg12 conjugate.
Found at: doi:10.1371/journal.pone.0008755.s006 (0.13 MB TIF)
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